Concord Medical Services Holdings Limited
CCM
$5.32
-$0.15-2.74%
NYSE
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -29.85% | -25.87% | -10.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -29.85% | -25.87% | -10.44% |
| Cost of Revenue | -- | -- | -25.92% | -25.47% | -16.25% |
| Gross Profit | -- | -- | -1.66% | 23.04% | 40.88% |
| SG&A Expenses | -- | -- | 15.60% | -10.25% | -5.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -9.91% | -20.07% | -12.45% |
| Operating Income | -- | -- | -13.30% | 12.87% | 14.58% |
| Income Before Tax | -- | -- | -18.93% | 20.77% | 28.91% |
| Income Tax Expenses | -- | -- | 31.29% | 88.79% | 78.31% |
| Earnings from Continuing Operations | -- | -- | -21.31% | 12.74% | 23.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 44.86% | 3.66% | -9.32% |
| Net Income | -- | -- | -2.68% | 21.60% | 31.89% |
| EBIT | -- | -- | -13.30% | 12.87% | 14.58% |
| EBITDA | -- | -- | -19.45% | 16.69% | 20.32% |
| EPS Basic | -- | -- | -2.68% | 21.60% | 31.89% |
| Normalized Basic EPS | -- | -- | 75.72% | -46.41% | -46.41% |
| EPS Diluted | -- | -- | -2.68% | 21.59% | 31.87% |
| Normalized Diluted EPS | -- | -- | 75.72% | -46.41% | -46.41% |
| Average Basic Shares Outstanding | -- | -- | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -- | -- | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |